Lactobacillus formulations with improved stability and efficacy
Abstract
A composition is provided herein directed to a mixture of one or more Lactobacillus sp. and a phenolic compound. In a specific embodiment, disclosed is a Lactobacillus /phenol mixture that has been lyophilized to form a Lactobacillus /phenol lyophilized mixture. The Lactobacillus /phenol mixture of Lactobacillus /phenol lyophilized mixture may be packaged in a capsule, emulsion, or tablet such that the Lactobacillus are protected in a gastrointestinal tract for transport to an intestine of a subject. In another embodiment, a method for treating indigestion, abdominal pain or cephalic syndrome in a subject including orally administering to the subject a composition comprising an effective amount of Lactobacillus /phenol mixture or lyophilized mixture. In still a further embodiment, of improving immune function in a subject, comprising administering to the subject, the composition comprising an effective amount of Lactobacillus /phenol mixture or lyophilized mixture.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for treating or alleviating symptoms of indigestion, abdominal pain or cephalic syndrome in a subject, a composition comprising an effective amount of comprising at least one Lactobacillus sp. and at least one phenolic compound.
2 . The method of claim 1 , wherein the at least one Lactobacillus sp. comprises Lactobacillus johnsonii.
3 . The method of claim 2 , wherein Lactobacillus johnsonii comprises Lactobacillus johnsonii N6.2.
4 . The method of claim 1 , wherein the at least one Lactobacillus sp. and at least one phenolic compound are combined as mixture, and, optionally, wherein the mixture is lyophilized.
5 . The method of claim 1 , wherein administering comprises oral administration.
6 . A method of improving immune function in a subject, comprising administering to the subject, a composition comprising an effective amount of comprising at least one Lactobacillus sp. and at least one phenolic compound.
7 . The method of claim 6 , wherein the at least one Lactobacillus sp. comprises Lactobacillus johnsonii.
8 . The method of claim 7 , wherein Lactobacillus johnsonii comprises Lactobacillus johnsonii N6.2.
9 . The method of claim 6 , wherein administering the composition increases expression of Toll like receptor 7 (TLR7) and Toll like receptor 9 (TLR9) in the subject.
10 . A composition comprising at least one Lactobacillus sp. and at least one phenolic compound, the composition being produced by:
mixing the at least one at least one Lactobacillus sp. and at least one phenolic compound to form a Lactobacillus /phenol mixture; and lyophilizing the Lactobacillus /phenol mixture to form a Lactobacillus /phenol lyophilized mixture.
11 . The composition of claim 10 , wherein the at least one phenolic compound is present in a plant extract.
12 . The composition of claim 11 , wherein the plant extract is a berry extract.
13 . The composition of claim 12 , wherein the berry extract is a dried powder that reconstituted in an aqueous solution prior to the mixing step.
14 . The method of claim 6 , wherein administering comprises oral, intravenous or rectal administration.
15 . (canceled)
18 . (canceled)
19 . (canceled)Join the waitlist — get patent alerts
Track US2023293607A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.